Mast cell-macrophage dynamics in modulation of dengue virus infection in skin

Immunology

Volumn 146, Issue 1, 2015, Pages 163-172

  Chu, Ya Ting ^a   Wan, Shu Wen ^a,b   Anderson, Robert ^c,d   Lin, Yee Shin ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c DALHOUSIE UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Dengue virus; KitW sh W sh mice; Macrophage; Mast cell

Indexed keywords

CHEMOKINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 3; VIRUS RNA; CCL2 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CXCL10 PROTEIN, MOUSE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; NS3 PROTEIN, FLAVIVIRUS; RANTES; RNA HELICASE; SERINE PROTEINASE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLEEDING TIME; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENGUE; DENGUE VIRUS; DISEASE PREDISPOSITION; EX VIVO STUDY; IMMUNOMODULATION; IN VIVO STUDY; INFECTION RISK; MAST CELL; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SKIN; VIRUS LOAD; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CXCL10; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; MACROPHAGES, PERITONEAL; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA HELICASES; RNA, VIRAL; SERINE ENDOPEPTIDASES; SKIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84938329548     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12492     Document Type: Article

References (40)

1. Whitehorn J, Farrar J. Dengue. Clin Med 2011; 11:483-7.
2. Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl J Med 2012; 366:1423-32.
3. Bhatt S, Gething PW, Brady OJ et al. The global distribution and burden of dengue. Nature 2013; 496:504-7.
4. Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 2013; 5:299-309.
5. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4:787-99.
6. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10:440-52.
7. Weller CL, Collington SJ, Williams T, Lamb JR. Mast cells in health and disease. Clin Sci 2011; 120:473-84.
8. Hu Y, Jin Y, Han D et al. Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J Virol 2012; 86:3347-56.
9. Aoki R, Kawamura T, Goshima F et al. Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. J Invest Dermatol 2013; 133:2170-9.
10. Tuchinda M, Dhorranintra B, Tuchinda P. Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1977; 8:80-3.
11. Furuta T, Murao LA, Lan NT et al. Association of mast cell-derived VEGF and proteases in Dengue shock syndrome. PLoS Negl Trop Dis 2012; 6:e1505.
12. St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife 2013; 2:e00481.
13. King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol 2002; 76:8408-19.
14. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000; 74:7146-50.
15. Brown MG, Hermann LL, Issekutz AC, Marshall JS, Rowter D, Al-Afif A, Anderson R. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol 2011; 85:1145-50.
16. Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, Marshall JS, Anderson R. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS ONE 2012; 7:e34055.
17. Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 2008; 111:5467-76.
18. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, Abraham SN. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci USA 2011; 108:9190-5.
19. St John AL. Influence of mast cells on dengue protective immunity and immune pathology. PLoS Pathog 2013; 9:e1003783.
20. Mallen-St Clair J, Pham CT, Villalta SA, Caughey GH, Wolters PJ. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest 2004; 113:628-34.
21. Wolters PJ, Mallen-St Clair J, Lewis CC, Villalta SA, Baluk P, Erle DJ, Caughey GH. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 2005; 35:82-8.
22. +, and expresses aminopeptidase N (CD13). Blood 1999; 94:2333-42.
23. Gilfillan AM, Austin SJ, Metcalfe DD. Mast cell biology: introduction and overview. Adv Exp Med Biol 2011; 716:2-12.
24. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167:835-48.
25. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor α are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007; 81:5518-26.
26. Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, Anderson R, Lin YS. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol 2009; 183:1797-803.
27. Séverin S, Gratacap MP, Lenain N et al. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 2007; 117:944-52.
28. Schlederer M, Mueller KM, Haybaeck J et al. Reliable quantification of protein expression and cellular localization in histological sections. PLoS ONE 2014; 9:e100822.
29. Wan SW, Lu YT, Huang CH et al. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS ONE 2014; 9:e92495.
30. Lee YR, Liu MT, Lei HY et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 2006; 87:3623-30.
31. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 2003; 116:4615-28.
32. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29:313-26.
33. Sierra B, Perez AB, Vogt K et al. MCP-1 and MIP-1α expression in a model resembling early immune response to dengue. Cytokine 2010; 52:175-83.
34. Zellweger RM, Shresta S. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol 2014; 5:151.
35. + dendritic cell and macrophage infection by dengue virus is stimulated by interleukin-4. J Invest Dermatol 2015; 135:1743-51.
36. Avirutnan P, Matangkasombut P. Unmasking the role of mast cells in dengue. Elife 2013; 2:e00767.
37. Yoshimura T, Ueda A. Monocyte chemoattractant protein-1. In: Aggarwal BB, Gutterman JU, eds. Human Cytokines: Handbook for Basic and Clinical Research, II. Cambridge: Blackwell Science, 1996: 198-221.
38. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989; 244:487-93.
39. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, Gladue R, Rollins B. In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol 1997; 62:577-80.
40. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. Multiplex cytokine profile from dengue patients: MIP-1β and IFN-γ as predictive factors for severity. BMC Infect Dis 2008; 8:86.